Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PKM | P14618 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1939702 | 0.96 | PKM (0.35) | PKM | |
| SCHEMBL2189598 | 0.84 | — | — | |
| SCHEMBL4887775 | 0.80 | — | — | |
| SCHEMBL14403170 | 0.80 | — | — | |
| SCHEMBL8941008 | 0.76 | PKM (0.44) | PKM | |
| SCHEMBL22660504 | 0.76 | — | — | |
| SCHEMBL11405480 | 0.76 | PKM (0.44) | PKM | |
| SCHEMBL14859331 | 0.74 | — | — | |
| SCHEMBL9905932 | 0.70 | — | — | |
| SCHEMBL732916 | 0.67 | GRIN1 (0.52) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116046926-B | Detection method of 1-bromo-3, 5-dimethyl adamantane related substances | 合肥久诺医药科技有限公司 | 2024-11-05 | — | — | CN | claimed |
| CN-104592035-B | A kind of synthetic method of 1,3-diaminourea-5,7-dimethyladamantane | 中钢集团鞍山热能研究院有限公司 | 2016-08-24 | — | — | CN | claimed |
| CN-116046926-B | Detection method of 1-bromo-3, 5-dimethyl adamantane related substances | 合肥久诺医药科技有限公司 | 2024-11-05 | — | — | CN | disclosed |
| CN-116046926-A | Detection method of 1-bromo-3, 5-dimethyl adamantane related substances | 合肥久诺医药科技有限公司 | 2023-05-02 | — | — | CN | disclosed |
| EP-3061742-A1 | 1,3-BIS(HYDROXYPHENYL)-5-ETHYLADAMANTANE COMPOUND AND METHOD FOR PRODUCTION THEREOF, AND AROMATIC POLYCARBONATE RESIN AND METHOD FOR PRODUCTION THEREOF | Mitsubishi Gas Chemical Company, Inc. (JP) | 2016-08-31 | — | — | EP | disclosed |
| US-20160244389-A1 | 1,3-BIS(HYDROXYPHENYL)-5-ETHYLADAMANTANE COMPOUND AND METHOD FOR PRODUCTION THEREOF, AND AROMATIC POLYCARBONATE RESIN AND METHOD FOR PRODUCTION THEREOF | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2016-08-25 | — | — | US | disclosed |
| CN-104592035-B | A kind of synthetic method of 1,3-diaminourea-5,7-dimethyladamantane | 中钢集团鞍山热能研究院有限公司 | 2016-08-24 | — | — | CN | disclosed |
| US-20160068756-A1 | RETARDATION FILM, METHOD OF MANUFACTURING RETARDATION FILM, LAMINATE, COMPOSITION, POLARIZING PLATE AND LIQUID CRYSTAL DISPLAY DEVICE | FUJIFILM CORPORATION (JP) | 2016-03-10 | — | — | US | disclosed |
| US-20160068756-A1 | RETARDATION FILM, METHOD OF MANUFACTURING RETARDATION FILM, LAMINATE, COMPOSITION, POLARIZING PLATE AND LIQUID CRYSTAL DISPLAY DEVICE | FUJIFILM CORPORATION (JP) | 2016-03-10 | — | — | US | disclosed |
| US-20120142879-A1 | COMPOSITION FOR FILM FORMATION, INSULATING FILM AND SEMICONDUCTOR DEVICE | SUMITOMO BAKELITE COMPANY LIMITED (JP) | 2012-06-07 | — | — | US | disclosed |
| EP-2457932-A1 | COMPOSITION FOR FILM FORMATION, INSULATING FILM, AND SEMICONDUCTOR DEVICE | Sumitomo Bakelite Company Limited (JP) | 2012-05-30 | — | — | EP | disclosed |
| WO-2007094746-A1 | 5,7-DIMETHYLADAMANTANE-1,3-DICARBOXYLIC ACID DIALKYL ESTERS, A METHOD FOR THE SYNTHESIS THEREOF AND METHOD FOR SYNTHESISING A 5,7-DIMETHYLADAMANTANE-1,3-DICARBOXYLIC ACID IN THE FORM OF AN INTERMEDIATE PRODUCT | GOLOVKO LEONID VLADIMIROVICH (UA) | 2007-08-23 | — | — | WO | disclosed |
| EP-1711550-A1 | ADAMANTYL MONOMERS AND POLYMERS FOR LOW-K-DIELECTRIC APPLICATIONS | Silecs OY (FI) | 2006-10-18 | — | — | EP | disclosed |
| WO-2005061587-A1 | ADAMANTYL MONOMERS AND POLYMERS FOR LOW-K-DIELECTRIC APPLICATIONS | SILECS OY (FI) | 2005-07-07 | — | — | WO | disclosed |
| US-6720460-B2 | FORMING HEAT RESISTANT, MECHANICAL STRENGTH POLYMER ADDITIVES; ACID CATALYZED REACTION OF ADAMANTANE DIOL OR TRIOL WITH PHENOLIC DERIVATIVE | HONSHU CHEMICAL INDUSTRY CO., LTD. (JP) | 2004-04-13 | — | — | US | disclosed |
| US-20030187307-A1 | Hydroxyphenyl adamantanes and process for the production of the same | HONSHU CHEMICAL INDUSTRY CO., LTD. (JP) | 2003-10-02 | — | — | US | disclosed |
| EP-1336597-A1 | Hydroxyphenyl adamantanes and process for the production of the same | Honshu Chemical Industry Co., Ltd. (JP) | 2003-08-20 | — | — | EP | disclosed |
| US-5017734-A | Ethynyl adamantane derivatives and methods of polymerization thereof | FLUOROCHEM INC., A CORP. OF CALIFORNIA | 1991-05-21 | — | — | US | disclosed |
| EP-0053621-B1 | UNSATURATED ESTERS OF ADAMANTANE CONTAINING DIOLS AND THERMO-RESISTANT CROSS-LINKED POLYMERS THEREFROM | BATTELLE MEMORIAL INSTITUTE (CH) | 1984-07-25 | — | — | EP | disclosed |
| US-4332964-A | Unsaturated esters of adamantane containing diols and thermo-resistant cross-linked polymers therefrom | BATTELLE DEVELOPMENT CORPORATION (US) | 1982-06-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030187307-A1 | Hydroxyphenyl adamantanes and process for the production of the same | CYP8B1, DHPS, P4HA1 | PKM 1812/4885 |
| US-20160244389-A1 | 1,3-BIS(HYDROXYPHENYL)-5-ETHYLADAMANTANE COMPOUND AND METHOD FOR PRODUCTION THEREOF, AND AROMATIC POLYCARBONATE RESIN AND METHOD FOR PRODUCTION THEREOF | PAH, CYP51A1, HPD | PKM 2733/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.